​

Cartesian Therapeutics (RNAC) Revenue & Revenue Breakdown

OverviewForecastFinancialsChart

Cartesian Therapeutics Revenue Highlights

Latest Revenue (Y)

$26.00M

Latest Revenue (Q)

$5.84M

Cartesian Therapeutics Revenue by Period

Cartesian Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$26.00M-76.53%
2022-12-31$110.78M30.21%
2021-12-31$85.08M412.60%
2020-12-31$16.60M-

Cartesian Therapeutics generated $26.00M in revenue during NA 2023, up -76.53% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Cartesian Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$5.84M-29.35%
2023-12-31$8.27M26.18%
2023-09-30$6.55M24.80%
2023-06-30$5.25M-11.60%
2023-03-31$5.94M-64.64%
2022-12-31$16.80M-18.90%
2022-09-30$20.71M-47.27%
2022-06-30$39.27M15.51%
2022-03-31$34.00M13.57%
2021-12-31$29.94M22.56%
2021-09-30$24.43M24.23%
2021-06-30$19.66M77.95%
2021-03-31$11.05M-

Cartesian Therapeutics generated $5.84M in revenue during Q1 2024, up -29.35% compared to the previous quarter, and up 34.77% compared to the same period a year ago.

RNAC Revenue FAQ

What is Cartesian Therapeutics’s yearly revenue?

Cartesian Therapeutics's yearly revenue for 2023 was $26M, representing a decrease of -76.53% compared to 2022. The company's yearly revenue for 2022 was $110.78M, representing an increase of 30.21% compared to 2021. RNAC's yearly revenue for 2021 was $85.08M, representing an increase of 412.60% compared to 2020.

What is Cartesian Therapeutics’s quarterly revenue?

Cartesian Therapeutics's quarterly revenue for Q1 2024 was $5.84M, a -29.35% decrease from the previous quarter (Q4 2023), and a -1.65% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $8.27M, a 26.18% increase from the previous quarter (Q3 2023), and a -50.78% decrease year-over-year (Q4 2022). RNAC's quarterly revenue for Q3 2023 was $6.55M, a 24.80% increase from the previous quarter (Q2 2023), and a -68.37% decrease year-over-year (Q3 2022).

What is Cartesian Therapeutics’s revenue growth rate?

Cartesian Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -69.43%